Atripla™ – HIV therapy in one pill

by Boris Julg, Johannes R Bogner
Published 2008-06-01

Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells

by Eva M. Grützner, Eva M. Grützner, Tanja Hoffmann, Eva Wolf, Elke Gersbacher, Ashley Neizert, Renate Stirner, Renate Stirner, Ramona Pauli, Albrecht Ulmer, Jürgen Brust, Johannes R. Bogner, Johannes R. Bogner, Hans Jaeger, Rika Draenert, Rika Draenert
Published 2018-04-01

Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele.

by Julia Roider, Anna-Lena Kalteis, Thomas Vollbrecht, Lisa Gloning, Renate Stirner, Nadja Henrich, Johannes R Bogner, Rika Draenert
Published 2013-01-01

High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

by Eva M. Grützner, Ashley Neizert, Renate Stirner, Raffaele Conca, Immanuel Andrä, Lisa Wolff, Matthias Schiemann, Lesca M. Holdt, Christoph Klein, Johannes R. Bogner, Rika Draenert
Published 2020-01-01

SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation

by Ariane Zutz, Christian Schölz, Stephanie Schneider, Virginia Pierini, Maximilian Münchhoff, Kathrin Sutter, Georg Wittmann, Ulf Dittmer, Rika Draenert, Johannes R. Bogner, Oliver T. Fackler, Oliver T. Keppler
Published 2020-01-01

Overnight resting of PBMC changes functional signatures of antigen specific T- cell responses: impact for immune monitoring within clinical trials.

by Sarah Kutscher, Claudia J Dembek, Simone Deckert, Carolina Russo, Nina Körber, Johannes R Bogner, Fabian Geisler, Andreas Umgelter, Michael Neuenhahn, Julia Albrecht, Antonio Cosma, Ulrike Protzer, Tanja Bauer
Published 2013-01-01

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected...

by Javier Morales-Ramirez, Johannes R Bogner, Jean-Michel Molina, Johan Lombaard, Ira B Dicker, David A Stock, Michelle DeGrosky, Margaret Gartland, Teodora Pene Dumitrescu, Sherene Min, Cyril Llamoso, Samit R Joshi, Max Lataillade
Published 2018-01-01

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.

by Daniel Schmidt, Christian Kollan, Gerd Fätkenheuer, Eugen Schülter, Hans-Jürgen Stellbrink, Christian Noah, Björn-Erik Ole Jensen, Matthias Stoll, Johannes R Bogner, Josef Eberle, Karolin Meixenberger, Claudia Kücherer, Osamah Hamouda, Barbara Bartmeyer, ClinSurv-HIV Drug Resistance Study Group in CHAIN
Published 2014-01-01

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospectiv...

by Guido Schäfer, Christian Hoffmann, Keikawus Arasteh, Dirk Schürmann, Christoph Stephan, Björn Jensen, Matthias Stoll, Johannes R. Bogner, Gerd Faetkenheuer, Jürgen Rockstroh, Hartwig Klinker, Georg Härter, Albrecht Stöhr, Olaf Degen, Eric Freiwald, Anja Hüfner, Sabine Jordan, Julian Schulze zur Wiesch, Marylyn Addo, Ansgar W. Lohse, Jan van Lunzen, Stefan Schmiedel, the IDEAL study group
Published 2019-11-01